Zdrowie i gospodarka · 12/10/2023
FDA Clears Path for Trametinib Dimethyl Sulfoxide Tablets
The FDA has determined that MEKINIST tablets, 1mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions of the medication.
Source: Federal Register — Food and Drug AdministrationOpen original release →